Related Experiment Video
Updated: Feb 24, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
6.0K
Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary
Polish Archives of Internal Medicine
|August 18, 2017
Summary
Switching to prasugrel may reduce periprocedural myocardial injury in patients with poor response to clopidogrel during percutaneous coronary intervention (PCI). This guided therapy shows potential for improved cardiovascular event risk reduction.
Area of Science:
- Cardiology
- Pharmacology
- Genetics
Background:
- Periprocedural myocardial injury increases cardiovascular event risk.
- Limited data exists on potent P2Y12 antagonists for patients with inadequate clopidogrel response.
- Elective percutaneous coronary intervention (PCI) requires effective antiplatelet strategies.
Purpose of the Study:
- To assess prasugrel's impact on periprocedural myocardial injury in PCI patients.
- To evaluate patients with inadequate response to clopidogrel, identified by genotyping and platelet function testing (PFT).
- To determine if guided antiplatelet therapy improves outcomes.
Main Methods:
- Interim analysis of the randomized ONSIDE TEST study.
- Patients randomized to genotyping, PFT, or control arms.
- Poor clopidogrel responders (via CYP2C19 genotyping or PFT) were switched to prasugrel (60 mg) before PCI.
Main Results:
- 26.6% of patients (25/94) showed inadequate response to clopidogrel.
- Prasugrel use in poor responders trended towards lower myocardial injury (61.5% vs. 91.7%).
- No significant difference in overall myocardial injury rates across initial study arms.
Conclusions:
- Guided early administration of prasugrel may reduce periprocedural myocardial injury.
- This strategy is particularly relevant for patients with stable coronary artery disease undergoing PCI.
- Personalized antiplatelet therapy based on genetic and functional testing shows promise.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:28Acute Coronary Syndrome IV: Interprofessional Care
332
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
332
01:27Peripheral Artery Disease III: Interprofessional Care
404
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
404
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.7K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.7K
01:27Coronary Artery Disease V: Interprofessional Care
325
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
325